Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Implementation of clinical pharmacy services in a pediatric dialysis unit
Pediatric Nephrology, Volume 29, No. 7, Year 2014
Notification
URL copied to clipboard!
Description
Background: End-stage renal disease patients on hemodialysis are on complex drug regimens consisting of multiple medications, many of which are administered in several doses per day. Consequently, such patients are at high risk for developing drug therapy-related problems (DTRPs). The aim of this study was to detect DTRPs in children undergoing hemodialysis and to assess and evaluate the impact of interventions by the clinical pharmacist on the clinical outcome of children undergoing hemodialysis. Methods: Fifty hemodialysis outpatients were randomly divided into two groups (25 each): the control group and the test group. During the 9-month study period, patients in the control group received the usual medical care, and those in the test group received pharmaceutical care 3 timesweekly in addition to the usual medical care. Results: After 9 months of pharmaceutical care implementation, the test group showed a significant decline in systolic and diastolic blood pressure (p=0.0001), serum phosphorus level (p=0.006) and parathyroid hormone level (p=0.001) versus their baseline values and versus the control. The serum Ca*P product level of the test group decreased (p=0.001) after intervention versus baseline. Serum calciumlevel significantly increased in test group (p=0.02) and decreased in the control group (p=0.001) versus the respective baseline values. Satisfaction with the renal treatment significantly improved in the test group (p=0.0001) versus the control group after 9 months of pharmaceutical care implementation based on Renal Treatment Satisfaction Questionnaire scores. Conclusions: Pharmacist-initiated pharmaceutical care improved the satisfaction and biochemical findings of patients on hemodialysis. © IPNA 2014.
Authors & Co-Authors
El Borolossy, Radwa Maher
Egypt, Cairo
Faculty of Pharmacy - Ain Shams University
El Wakeel, Lamia Mohamed
Egypt, Cairo
Faculty of Pharmacy - Ain Shams University
El-Hakim, Ihab Zaki
Egypt, Cairo
Faculty of Medicine - Ain Shams University
Badary, Osama Ahmed
Egypt, Cairo
Faculty of Pharmacy - Ain Shams University
Statistics
Citations: 11
Authors: 4
Affiliations: 2
Identifiers
Doi:
10.1007/s00467-014-2760-4
ISSN:
0931041X
e-ISSN:
1432198X
Research Areas
Health System And Policy
Maternal And Child Health
Noncommunicable Diseases
Study Design
Randomised Control Trial